These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16763789)

  • 1. HPLC analysis of K-48 concentration in plasma.
    Kalász H; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Gergely A; Tekes K
    Anal Bioanal Chem; 2006 Jul; 385(6):1062-7. PubMed ID: 16763789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.
    Tekes K; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Kalász H
    J Chromatogr A; 2006 Jul; 1122(1-2):84-7. PubMed ID: 16690067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
    Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
    Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma.
    Karasova JZ; Chladek J; Hroch M; Josef F; Hnidkova D; Kuca K
    J Appl Toxicol; 2013 Jan; 33(1):18-23. PubMed ID: 21717485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in concentration of two clinically used acetylcholinesterase reactivators (HI-6 and obidoxime) in rat plasma determined by HPLC techniques after in vivo administration.
    Zdarova Karasova J; Novotny L; Antos K; Zivna H; Kuca K
    Anal Sci; 2010 Jan; 26(1):63-7. PubMed ID: 20065589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model.
    Worek F; Szinicz L; Eyer P; Thiermann H
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):193-202. PubMed ID: 15904945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification of pralidoxime chloride-loaded solid lipid nanoparticles for enhanced brain reactivation of organophosphorus-inhibited AChE: Pharmacokinetics in rat.
    Buzyurova DN; Pashirova TN; Zueva IV; Burilova EA; Shaihutdinova ZM; Rizvanov IK; Babaev VM; Petrov KA; Souto EB
    Toxicology; 2020 Nov; 444():152578. PubMed ID: 32898602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo metabolisms of K-48.
    Benko B; Kalász H; Ludányi K; Petroianu G; Kuca K; Darvas F; Tekes K
    Anal Bioanal Chem; 2007 Oct; 389(4):1243-7. PubMed ID: 17768608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partition of bispyridinium oximes (trimedoxime and K074) administered in therapeutic doses into different parts of the rat brain.
    Karasova JZ; Zemek F; Bajgar J; Vasatova M; Prochazka P; Novotny L; Kuca K
    J Pharm Biomed Anal; 2011 Apr; 54(5):1082-7. PubMed ID: 21146949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Oxime Encapsulation on Acetylcholinesterase Reactivation: Pharmacokinetic Study of the Asoxime-Cucurbit[7]uril Complex in Mice Using Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry.
    Andrýs R; Klusoňová A; Lísa M; Kassa J; Karasová JŽ
    Mol Pharm; 2021 Jun; 18(6):2416-2427. PubMed ID: 34019427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a sensitive HPLC method for the quantification of HI-6 in guinea pig plasma and evaluated in domestic swine.
    Bohnert S; Vair C; Mikler J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1407-13. PubMed ID: 20395179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of K-27, an oxime-type cholinesterase reactivator by high-performance liquid chromatography with electrochemical detection from different biological samples.
    Gyenge M; Kalász H; Petroianu GA; Laufer R; Kuca K; Tekes K
    J Chromatogr A; 2007 Aug; 1161(1-2):146-51. PubMed ID: 17603065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime.
    Lorke DE; Hasan MY; Nurulain SM; Sheen R; Kuca K; Petroianu GA
    J Appl Toxicol; 2007; 27(5):482-90. PubMed ID: 17309042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
    Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
    J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HI-6 oxime (an acetylcholinesterase reactivator): blood plasma pharmacokinetics and organ distribution in experimental pigs.
    Kuneš M; Květina J; Bureš J; Karasová JZ; Pavlík M; Tachecí I; Musílek K; Kuca K
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():191-6. PubMed ID: 25638385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on medicinal chemistry of K203 in wistar rats and beagle dogs.
    Kalász H; Szegi P; Jánoki G; Balogh L; Pöstényi Z; Musilek K; Petroianu GA; Siddiq A; Tekes K
    Curr Med Chem; 2013; 20(16):2137-44. PubMed ID: 23531217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.